Pharm part 4 Flashcards
Common indications of H2 blockers
Short-term tx of active duodenal ulcer, GERD, erosive esophagitis, gastritis
MOA of H2 blockers
Competitively and reversibly inhibits histamine at H2 receptors on gastric cells
Common AEs of H2 blockers
Abd pain
Constipation
Diarrhea
HA
Clinically sig drug interactions of H2 blockers
May decrease warfarin clearance
Major counseling points of H2 blockers
May be taken with food if GI upset occurs
Prolonged tx greater than or equal to 2 yrs may lead to vitamin B12 malabsorption
Monitoring parameters of H2 blockers
Improvement in GI S/sx
Common indications for alpha blockers
HTN
BPH
MOA of alpha blockers
HTN: Competitively inhibits postsynaptic alpha-adrenergic receptors which results in vasodilation of veins and arterioles and a decrease in total peripheral resistance and blood pressure
BPH: Competitively inhibits postsynaptic alpha-adrenergic receptors in prostatic stromal and bladder neck tissues. This reduces the sympathetic tone-induced urethral stricture causing BPH sx
Common AEs of alpha blockers
Dizziness
Fatigue
Orthostatic hypotension
HA
Renal or hepatic dose adjustments for alpha blockers
Use with caution in mild-to-moderate hepatic dysfunction
Do not use with severe impairment
Clinically sig drug interactions with alpha blockers
PDE-5 inhibitors
Monitoring parameters of alpha blockers
Decrease in BP
Urinary retention
Common indications of duloxetine
MDD
Neuropathic pain associated with diabetic peripheral neuropathy
GAD
MOA of duloxetine
Inhibits neuronal reuptake of serotonin and norepinephrine primarily, and dopamine to a slight extent
Common AEs of duloxetine
Nausea Dry mouth Constipation Insomnia Dizziness
Renal or hepatic dose adjustments of duloxetine
CrCl <30: use not recommended
Mild-mod renal impairment use low dosing
Not recommended in hepatic impairment
BBW for duloxetine
Antidepressants increase risk of suicidal thinking and behavior in children, adolescents, and young adults with MDD and other psychiatric d/os
Clinically significant drug interactions of duloxetine
CI-ed with MAOIs, inhibitors of CYP1A2 and CYP2DC increase levels of duloxetine. Chronic use of NSAIDs increases risk of GI bleeds.
Major counseling points of duloxetine
Pay close attention to mood or behavioral changes- this drug may increase suicidal thoughts or actions.
Benefits may not be seen before 2 wks of continued drug therapy;
May cause drowsiness; Avoid alcohol while taking this medication
Do not abruptly d/c
Store in a cool, dry place…
If a dose is missed, skip it and return to nl dosing schedule
Monitoring parameters of duloxetine
Improvement in S/sx of anxiety/depression/pain
Abrupt changes in mood